- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Radiologix’s revenue rises
Revenue for radiology service networks operator Radiologix increased by 37% in the first quarter of 2000 (ending March 31). First-quarter revenue was $59.3 million compared to $43.2 million for the first quarter of 1999. Net income increased 5% to $4.1
Revenue for radiology service networks operator Radiologix increased by 37% in the first quarter of 2000 (ending March 31). First-quarter revenue was $59.3 million compared to $43.2 million for the first quarter of 1999. Net income increased 5% to $4.1 million in the first quarter of 2000, compared to $3.9 million in the first quarter of 1999.
Radiologix gains most of its revenue from service fees associated with the production and management of diagnostic imaging, including MR, ultrasound, CT, mammography, nuclear medicine and PET, along with general radiography and fluoroscopy. The companys freestanding radiology centers provide services that have been outsourced by hospitals.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
